Free Trial
NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Price, News & Analysis

Creative Medical Technology logo
$3.25 +0.14 (+4.53%)
As of 09/25/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Creative Medical Technology Stock (NASDAQ:CELZ)

Advanced

Key Stats

Today's Range
$3.11
$3.34
50-Day Range
$2.62
$3.73
52-Week Range
$1.69
$6.90
Volume
35,285 shs
Average Volume
28,401 shs
Market Capitalization
$8.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Creative Medical Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

CELZ MarketRank™: 

Creative Medical Technology scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Creative Medical Technology are expected to grow in the coming year, from ($3.19) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Creative Medical Technology is -1.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Creative Medical Technology is -1.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Creative Medical Technology has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Creative Medical Technology's valuation and earnings.
  • Percentage of Shares Shorted

    4.64% of the float of Creative Medical Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Creative Medical Technology has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Creative Medical Technology has recently decreased by 18.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Creative Medical Technology does not currently pay a dividend.

  • Dividend Growth

    Creative Medical Technology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.64% of the float of Creative Medical Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Creative Medical Technology has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Creative Medical Technology has recently decreased by 18.29%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Creative Medical Technology has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.02 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Creative Medical Technology this week, compared to 0 articles on an average week.
  • Search Interest

    6 people have searched for CELZ on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Creative Medical Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.80% of the stock of Creative Medical Technology is held by insiders.

  • Percentage Held by Institutions

    Only 1.42% of the stock of Creative Medical Technology is held by institutions.

  • Read more about Creative Medical Technology's insider trading history.
Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CELZ Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

CELZ Stock Analysis - Frequently Asked Questions

Creative Medical Technology's stock was trading at $2.31 at the beginning of 2025. Since then, CELZ shares have increased by 40.7% and is now trading at $3.25.

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its quarterly earnings data on Friday, August, 8th. The company reported ($0.48) EPS for the quarter, beating the consensus estimate of ($0.63) by $0.15.

Shares of Creative Medical Technology reverse split on the morning of Sunday, June 11th 2023.The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creative Medical Technology investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL) and ChargePoint (CHPT).

Company Calendar

Last Earnings
8/08/2025
Today
9/25/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELZ
CIK
1187953
Fax
N/A
Employees
5
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($3.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.49 million
Net Margins
N/A
Pretax Margin
-96,066.66%
Return on Equity
-82.99%
Return on Assets
-79.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
23.86
Quick Ratio
23.86

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
838.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.63 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
2,580,000
Free Float
2,508,000
Market Cap
$8.39 million
Optionable
Not Optionable
Beta
2.06
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:CELZ) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners